Effects of fructose-1,6-diphosphate on endo- and myocardial purine metabolism during coronary artery bypass grafting surgery

Journal of Cardiovascular Surgery

Volumn 48, Issue 6, 2007, Pages 751-756

  Gal, Janos ^a,d   Riedel, B ^a   Kertai, M D ^a,b   Jancso, G ^c   Acsady, G ^b   Royston, D ^a   Roth, E ^c  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Cardiac surgical procedures; Coronary artery bypass grafting; Fructose 1,6 diphosphate; Heart; Reperfusion injury

Indexed keywords

ANTIANGINA PECTORIS AGENT; FRUCTOSE 1,6 BISPHOSPHATE; GLUCOSE; HYPOXANTHINE; INOSINE; PLACEBO;

ARTICLE; BLOOD SAMPLING; CHROMATOGRAPHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ELECTIVE SURGERY; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; PURINE METABOLISM; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL;

CARDIOVASCULAR AGENTS; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FRUCTOSEDIPHOSPHATES; HUMANS; MYOCARDIUM; PLACEBOS; PURINES; TIME FACTORS;

EID: 37249061228     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Klatte K, Chaitman BR, Theroux P, Gavard JA, Stocke K, Boyce S et al. Increased mortality after coronary artery bypass grafting surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial. J Am Coll Cardiol 2001;38:1070-7.
2. Tavazzi B, Cerroni L, Di Pierro D, Lazzarino G, Nuutinen M, Starnes JW et al. Oxygen radical injury and loss of high-energy compounds in anoxic and reperfused rat heart: prevention by exogenous fructose-1, 6-diphosphate. Free Radic Res Commun 1990;10:167-76.
3. Chien S, Zhang F, Niu W, Ehringer W, Chiang B, Shi X et al. Fructose-1, 6-diphosphate and a glucose-free solution enhances functional recovery in hypothermic heart preservation. J Heart Lung Transplant 2000;19:277-85.
4. Merli M, Bergui G, Cattani C, Berti F, Marchetti M. Recovery of post-arrest cardiac performance: effect of fructose-1, 6-diphosphate in the isolated rabbit heart. Riv Eur Sci Med Farmacol 1989;11:175-82.
5. Janz TG, Leasure J, Olson JE. The effects of Fructose-1, 6-diphosphate on myocardial damage in acute coronary artery occlusion. Resuscitation 1991;22:45-54.
6. Grandi AM, Muggia C, Barzizza F, Venco A, Finardi G. Improved left ventricular function after short-term treatment with fructose-1, 6-diphosphate: echocardiographic study in chronic ischemic heart disease and idiopathic dilated cardiomyopathy. Clin Ther 1988;10:372-80.
7. Munger MA, Botti RE, Grinblatt MA, Kasmer RJ. Effect of intravenous fructose-1, 6-diphosphate on myocardial contractility in patients with left ventricular dysfunction. Pharmacotherapy 1994;14:522-8.
8. Marchionni N, Conti A, De Alfieri W, Di Bari M, Ferrucci L, Lombardi A et al. Hemodynamic and electrocardiographic effects of fructose-1, 6-diphosphate in acute myocardial infarction. Am J Cardiol 1985;56:266-9.
9. Markov AK, Didlake RH. Improvement of hemodynamics and pulmonary function following fructose-1, 6-diphosphate administration in ARDS patients. Microcirc 1987;1:173-7.
10. Prinzen FW, Van der Vusse GJ, Arts T, Roemen TH, Coumans WA, Reneman RS. Accumulation of nonesterified fatty acids in ischemic canine myocardium. Am J Physiol 1984;247:H264-72.
11. Smolenski RT, Skladanowski AC, Perko M, Zydowo MM. Adenylate degradation product release from the human myocardium during open heart surgery. Clin Chim Acta 1989;182:63-74.
12. Smolenski RT, Lachno DR, Ledingham SJ, Yacoub MH. Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation. J Chromatogr 1990;27:414-20.
13. Andreoli SP. Mechanisms of endothelial cell ATP depletion after oxidant injury. Pediatr Res 1989;25:97-101.
14. Gál J, Riedel BJ, Bogár L, Tekeres M, Royston D. Using fruktose-1, 6-diphosphate during coronary artery bypass graft surgery. Anaesth. and Intensive Th 1999;2:78-86.
15. Riedel BJ, Gal J, Ellis G, Marangos PJ, Fox AW, Royston D. Myocardial protection using fructose-1, 6-diphosphate during coronary artery bypass graft surgery: a randomized, placebo-controlled clinical trial. Anesth Analg 2004;98:20-9.
16. Riedel B, Hughes J, Gal J, Gray C, Amrani M, Royston D. Coronary endothelial cytoprotection by fructose-1, 6-diphosphate (FDP) in a rat Langendorff model. Eur J Anaesthesiol 2000;17:A180.
17. Warltier DC, Pagel PS, Kersten JR. Approaches to the prevention of perioperative myocardial ischemia. Anesthesiology 2000;92:253-9.